By Stanley Senya
Accra, Nov. 19, GNA – Drug-resistant bacterial infections could cost Ghana an estimated US$435 million annually between 2024 and 2030, the Pharmaceutical Society of Ghana (PSGH) has warned.
The Society said the projected economic burden included approximately US$105 million in healthcare-provider costs and US$97 million in direct medical expenses borne by patients and caregivers, alongside significant productivity losses.
It said antimicrobial resistance (AMR) had become a major public health and development threat, contributing to treatment failures, prolonged illnesses, rising healthcare costs, disabilities and preventable deaths.
The PSGH gave the warning in a statement to commemorate the 2026 World Antimicrobial Resistance Awareness Week (WAAW), being observed from November 18 to 24, under the theme: “One Health, One Action: Prevent AMR Now!”
It explained that AMR occurred when microorganisms, including bacteria, viruses, fungi and parasites, developed resistance to medicines designed to eliminate or control them, making infections increasingly difficult or sometimes impossible to treat.
The Society said the problem could also undermine essential medical interventions such as surgery, cancer treatment, organ transplantation and childbirth.
It noted that the misuse of antimicrobial medicines in agriculture, livestock production and aquaculture, as well as environmental contamination from pharmaceutical waste and untreated wastewater, contributed to the emergence and spread of resistance.
The PSGH said the consequences extended beyond human health to threaten food security, livelihoods, economic growth and environmental sustainability.
It called on the Government and relevant stakeholders to strengthen the implementation, financing, coordination and monitoring of Ghana’s National Action Plan on AMR.
The Society also urged the Government to align the country’s response with the updated Global Action Plan on Antimicrobial Resistance (2026–2036), adopted at the 79th World Health Assembly in May 2026.
The global framework prioritises infection prevention and control, vaccination, water, sanitation and hygiene, responsible antimicrobial use, strengthened surveillance and research, environmental protection and sustainable financing.
The PSGH said pharmacists had an important role in combating AMR through appropriate antimicrobial selection, dispensing, monitoring, patient education, infection prevention and surveillance.
It said it had contributed to strengthening antimicrobial stewardship in Ghana, including facilitating the country’s participation in the Commonwealth Partnership for Antimicrobial Stewardship between 2018 and 2019.
The initiative, implemented by the Tropical Health and Education Trust (THET) and the Commonwealth Pharmacists Association, had supported the training of healthcare professionals as AMR Stewards, Champions and Fellows.
The Society called on healthcare facilities to institutionalise antimicrobial stewardship programmes, supported by multidisciplinary teams, adequate resources and routine monitoring.
It further urged regulators to intensify enforcement against inappropriate antimicrobial sales and the circulation of substandard and falsified medicines.
The PSGH encouraged stakeholders in human, animal, agricultural and environmental health to coordinate efforts to promote responsible antimicrobial use, improve vaccination and biosecurity, strengthen sanitation and ensure the safe disposal of pharmaceutical waste.
It also urged the public to avoid self-medication, use antibiotics only on the advice of qualified healthcare professionals, purchase medicines from licensed pharmacies and complete prescribed treatments as directed.
GNA
Edited by Benjamin Mensah